Скачать или смотреть Post-EV/Pembro Progression: How Real-World Data is Shaping 2L Treatment Decisions

A virtual roundtable, hosted by Dr. Petros Grivas of Fred Hutchinson Cancer Center, contextualized the latest bladder cancer research updates and trials of relevancy to come out of the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium. Dr. Grivas was joined by Drs. Guru Sonpavde, Elizabeth Plimack, Christopher Wallis, Terence Friedlander, and Matthew Galsky.

In the third segment of the roundtable, the panel covers second-line treatment options for metastatic urothelial cancer post-EV/pembro, with emphasis on platinum-based chemotherapy, targeted therapies, and the need for better data to guide sequencing. They summarize findings from the NIAGARA and CheckMate 274 trials on perioperative immunotherapy, while also highlighting the importance of multidisciplinary care and evolving bladder-preserving strategies.